What is GLP-1 (Glucagon-like peptide-1) microdosing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Definition of GLP-1

  • GLP-1, or Glucagon-like peptide-1, is a secreted peptide that plays a key role in blood glucose homeostasis 1.
  • It is a 30-amino acid peptide hormone produced in the intestinal epithelial endocrine L-cells by differential processing of proglucagon 2.

Functions of GLP-1

  • GLP-1 slows gastric emptying, enhances pancreatic insulin secretion, and suppresses pancreatic glucagon secretion 1.
  • It stimulates insulin secretion, inhibits glucagon secretion, and contributes to limiting postprandial glucose excursions 2.
  • GLP-1 also inhibits gastrointestinal motility and secretion, acts as an enterogastrone, and is part of the "ileal brake" mechanism 2.
  • Additionally, GLP-1 appears to be a physiological regulator of appetite and food intake 2.

GLP-1 Microdosing

  • There is no direct evidence in the provided studies to define GLP-1 microdosing.
  • However, the studies discuss the use of GLP-1 receptor agonists, which are biochemically modified for enhanced potency and sustained action, and are successfully used in clinical practice for the treatment of type-2 diabetes 3.
  • The therapeutic effects of GLP-1 receptor agonists are not entirely congruent with the physiological actions of GLP-1, and the relationships between these effects are not fully understood 4.

Therapeutic Applications of GLP-1

  • GLP-1 or GLP-1 receptor agonists are being evaluated for the therapy of type 2 diabetes 1, 5, 3.
  • GLP-1-based pharmacotherapies are also in clinical evaluation for the treatment of obesity 3.
  • GLP-1 has emerged as a pleiotropic hormone with a myriad of metabolic functions, making it an interesting candidate for the development of pharmacotherapies to treat various diseases 3.

References

Research

Regulation of glucose homeostasis by GLP-1.

Progress in molecular biology and translational science, 2014

Research

The physiology of glucagon-like peptide 1.

Physiological reviews, 2007

Research

Glucagon-like peptide 1 (GLP-1).

Molecular metabolism, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.